HOLX
Hologic, Inc. (HOLX) ESG Analysis Analysis (2026)
Environmental
HOLX’s R&D intensity near 6.0% of revenue supports product innovation with limited direct environmental burden, broadly in line with large medtech peers.
The company’s capital structure appears moderately conservative, which can reduce balance-sheet pressure to defer environmental compliance spending versus more leveraged peers.
No provided metrics indicate unusually high energy, emissions, or waste exposure, but the absence of disclosed environmental data limits evidence of a peer-leading profile.
As a medical device manufacturer, HOLX faces ongoing regulatory and product stewardship expectations, yet its current metrics do not show a clear environmental disadvantage versus peers.
Social
HOLX’s core diagnostics and surgical technologies support patient health outcomes, which is a structurally favorable social factor relative to broader industrial peers.
R&D spending around 6.0% of revenue suggests sustained investment in product quality and clinical relevance, supporting social positioning versus less innovation-intensive peers.
Stock-based compensation at roughly 2.0% of revenue indicates moderate employee incentive alignment without the heavier dilution burden seen at some growth-oriented peers.
No major labor, safety, or product controversy is provided, so HOLX appears socially solid relative to medtech peers, though not clearly best-in-class.
Governance
Debt-to-equity of 0.48 and net debt-to-EBITDA of 0.35 indicate restrained leverage, which lowers governance risk from financial stress versus more indebted peers.
Stock-based compensation at about 2.0% of revenue is manageable, suggesting compensation discipline relative to peers with more aggressive equity issuance.
R&D intensity near 6.0% of revenue implies disciplined reinvestment oversight, supporting governance quality through sustained but not excessive capital allocation.
The provided metrics do not reveal major governance red flags, and HOLX appears better positioned than peers with higher leverage or weaker capital discipline.
Overall Score
HOLX screens as a generally strong ESG performer versus peers, led by disciplined leverage and solid social positioning, with environmental evidence less complete.
Score Driver: Conservative Leverage And Disciplined Capital Allocation Versus Peers
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Hologic, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

